199982-19-9

Upstream product

• 619-65-8 4-cyanobenzoic Acid 
• 1571-08-0 methyl 4-formylbenzoate 
• 193821-09-9 N-benzyl-(4-methoxycarbonylphenyl)methanimine 
• 100-46-9 benzylamine 
• 190655-55-1 methyl 4-((benzylamino)methyl)benzoate 
• 199982-18-8 methyl 4-((benzyl(tert-butoxycarbonyl)amino)methyl)benzoate 

Downstream Products

• 335342-59-1 N-(tert-butoxycarbonyl)-N-benzyl-4-(bromomethyl)benzylamine 
• 575452-21-0 benzyl-{4-[2-(2,5,8,11,18,21,24,27-octaoxa-tricyclo[26.4.0.0^12,17]dotriaconta-1⁽²⁸⁾,12,14,16,29,31-hexaen-14-yl)-vinyl]-benzyl}-carbamic acid tert-butyl ester 
• 575452-19-6 benzyl-(4-iodomethyl-benzyl)-carbamic acid tert-butyl ester 
• 575452-18-5 benzyl-(4-chloromethyl-benzyl)-carbamic acid tert-butyl ester 
• 199982-20-2 N-(tert-butoxycarbonyl)-N-benzyl-4-formylbenzylamine 

Relevant academic research and scientific papers

Benzothiazole Formulations and Use Thereof

The present invention is related to macrogol glyceride pharmaceutical formulations containing benzothiazole derivatives. In particular, the invention is related to benzothiazole stearoyl macrogol pharmaceutical formulations, method of preparation and use thereof.

Tetrathiafulvalene-containing pseudorotaxanes formed between dibenzylammonium salts and crown ethers

The synthesis of two tetrathiafulvalene (TTF) derivatives, one carrying arms incorporating four dibenzylammonium centers and the other encompassing two annulated crown ether rings - i.e., hydrogen bond donor and acceptor functions, respectively, is described. In the presence of macrocyclic polyethers - e.g., DB24C8 and BPP34C10 - and dibenzylammonium hexafluorophosphate, these two TTF derivatives form pseudorotaxanes as evidenced by 1H NMR spectroscopy, mass spectrometry, and differential pulse voltammetry.

Multiply stranded and multiply encircled pseudorotaxanes

The self-assembly of four multicomponent rotaxane-like complexes, in which either (a) three or four dibenzo-[24]crown-8 rings encircle threadlike oligoammonium cations [PhCH2(NH2+CH2C6H4CH2